Carcinogenesis, Vol. 20, No. 3, 391-394,
March 1999
© 1999 Oxford University Press
Cytotoxic and mutagenic response of mismatch repair-defective human cancer cells exposed to a food-associated heterocyclic amine
Department of Genetic and Cellular Toxicology, Merck Research Laboratories, WP45-320, West Point, PA 19486, USA
The cytotoxic and mutagenic effects of 2-amino-1-methyl-6-phenylimidazo-[4,5-b]-pyridine (PhIP), a food-associated heterocyclic amine, were measured in three human cancer cell lines possessing different mismatch repair (MMR) defects and in matched cell lines corrected for the MMR deficiencies by specific chromosome transfer. Cells deficient in MMR were more resistant to PhIP-induced cytotoxicity and displayed ~3-fold more induced mutations at the hypoxanthine-guanine phosphoribosyl transferase locus. These results suggest that defects in MMR carried by patients with hereditary nonpolyposis colorectal cancer syndrome may result in enhanced sensitivity to certain dietary and environmental carcinogens such as PhIP.
Abbreviations: HAs, heterocyclic amines; HNPCC, hereditary nonpolyposis colorectal cancer; HPRT, hypoxanthine-guanine phosphoribosyl transferase; MMR, mismatch repair; PhIP, 2-amino-1-methyl-6-phenylimidazo-[4,5-b]-pyridine; 6-TG, 6-thioguanine.
1 To whom correspondence should be addressed Email: warren_glaab{at}merck.com
![]()
CiteULike
Connotea
Del.icio.us What's this?
This article has been cited by other articles:
![]() |
S. Creton, H. Zhu, and N. J. Gooderham A Mechanistic Basis for the Role of Cycle Arrest in the Genetic Toxicology of the Dietary Carcinogen 2-Amino-1-methyl-6-phenylimidazo[4,5-b]pyridine (PhIP) Toxicol. Sci., April 1, 2005; 84(2): 335 - 343. [Abstract] [Full Text] [PDF] |
||||
![]() |
P. Karran Mechanisms of tolerance to DNA damaging therapeutic drugs Carcinogenesis, December 1, 2001; 22(12): 1931 - 1937. [Abstract] [Full Text] [PDF] |
||||
![]() |
W. E. Glaab, K. L. Kort, and T. R. Skopek Specificity of Mutations Induced by the Food-associated Heterocyclic Amine 2-Amino-1-methyl-6-phenylimidazo-[4,5-b]-pyridine in Colon Cancer Cell Lines Defective in Mismatch Repair Cancer Res., September 1, 2000; 60(17): 4921 - 4925. [Abstract] [Full Text] |
||||
![]() |
W.-D. Chen, J. R. Eshleman, M. R. Aminoshariae, A.-H. Ma, N. Veloso, S. D. Markowitz, W. D. Sedwick, and M. L. Veigl Cytotoxicity and Mutagenicity of Frameshift-Inducing Agent ICR191 in Mismatch Repair-Deficient Colon Cancer Cells J Natl Cancer Inst, March 15, 2000; 92(6): 480 - 485. [Abstract] [Full Text] [PDF] |
||||



